富血小板血浆注射治疗踝关节骨关节炎
这项52周随访的随机对照试验将100例踝关节骨关节炎患者随机分为富血小板血浆(PRP)组或安慰剂(生理盐水)组,分别于纳入时和6周后接受2次踝关节腔内注射。PRP组在52周内的美国骨科足踝协会评分与安慰剂组相比差异为-2分(95%CI,-5至2;P=0.31),所有次要结局指标均无显著组间差异。
要点
- PRP注射未改善踝关节骨关节炎患者52周内的踝关节症状和功能。
- 52周内AOFAS评分组间校正差异为-2分(95%CI,-5至2;P=0.31),利于安慰剂组。
- 所有次要结局指标均未观察到显著组间差异。
核心结论
- 对于踝关节骨关节炎患者,与安慰剂注射相比,PRP注射未改善52周内的踝关节症状和功能。
研究设计与样本
- 随机对照试验,证据等级1级。
- 100例踝关节骨关节炎患者随机分为PRP组或安慰剂(生理盐水)组,分别于纳入时和6周后接受2次踝关节腔内注射。
- 随访52周,采用患者报告结局指标评估疼痛、功能、生活质量和间接费用。
主要发现
- 2例患者(2%)失访。
- 52周内患者报告的美国骨科足踝协会评分组间校正差异为-2分(95%CI,-5至2;P=0.31),利于安慰剂组。
- 所有次要结局指标均未观察到显著组间差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ankle osteoarthritis is debilitating and usually affects relatively young people, often as a result of previous ankle traumas, frequently occurring in sports. Platelet-rich plasma (PRP) injections for ankle osteoarthritis have shown no evidence of benefit over the course of 26 weeks. Previous studies on PRP for knee osteoarthritis showed that clinically significant improvements with PRP occurred between 6 to 12 months in the absence of initial benefit. No studies have evaluated the effect of PRP from 6 to 12 months in ankle osteoarthritis. PURPOSE: To assess the efficacy of PRP injections in ankle osteoarthritis over the course of 52 weeks. STUDY DESIGN: Randomized controlled trial; Level of evidence, 1. METHODS: In this 52-week follow-up trial, 100 patients with ankle osteoarthritis were randomized to a PRP group or placebo (saline) group. Patients received 2 intra-articular talocrural injections: at inclusion and after 6 weeks. Patient-reported outcome measures were used to assess pain, function, quality of life, and indirect costs over 52 weeks. RESULTS: Two patients (2%) were lost to follow-up. The adjusted between-group difference for the patient-reported American Orthopaedic Foot & Ankle Society score over 52 weeks was -2 points (95% CI, -5 to 2; P = .31) in favor of the placebo group. No significant between-group differences were observed for any of the secondary outcome measures. CONCLUSION: For patients with ankle osteoarthritis, PRP injections did not improve ankle symptoms and function over 52 weeks compared with placebo injections. REGISTRATION: NTR7261 (Netherlands Trial Register).
引用
- Paget LDA, Reurink G, de Vos RJ, et al. Platelet-Rich Plasma Injections for the Treatment of Ankle Osteoarthritis. Am J Sports Med. 2023. PMID: 37417359. doi:10.1177/03635465231182438
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。